Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Pharma
AZ, Daiichi's Enhertu notches another win in early breast cancer
The two positive trials could set Enhertu as a "foundational" treatment in the curative-intent breast cancer setting, AZ and Daiichi said.
Zoey Becker
Sep 29, 2025 12:00pm
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
Sep 24, 2025 10:16am
BMS JV sale, biotech debuts, possible deals—Fierce Pharma Asia
Sep 19, 2025 8:36am
Lilly reveals plan for $5B API production facility in Virginia
Sep 16, 2025 10:30am
China deals, Daiichi-Merck ADC, Sun Pharma—Fierce Pharma Asia
Sep 11, 2025 8:50pm